Greater Glasgow and Clyde Medicines

Medicines Update Extra

Medicines Update Extra provides a summary of the evidence base for medicines and therapies. It gives a ready reference for busy health professionals. 

Please note, the development of Medicines Update Extra bulletins will cease as of February 2022. Some existing publications have been identified to be replaced with Medicines Update blogs and will remain available until a review has taken place. All existing publications are greater than 3 years old and therefore should be used with caution as prescribing information can change. Always refer to the latest version of the manufacturer's summary of product characteristics (SPC) at http://emc.medicines.org.uk.

If you would like to access a bulletin that has been archived or have any questions around this, please email medicines.update@ggc.scot.nhs.uk. 

  

 

 

 

MUE 08: Drug induced QT prolongation

Posted: Friday, July 13, 2018

Category - Medicines Update Extra

MUE 08: Drug induced QT prolongation

** This bulletin supersedes MUE 02 **

  • Prolongation of the QT interval can lead to a life threatening arrhythmia known as torsades de pointes.
  • Over the last few years a number of warnings have highlighted the risk of QT prolongation with citalopram, domperidone, ondansetron, hydroxyzine and quinine.
  • Extra vigilance is required by healthcare professionals to be alert to the risk of drug induced QT prolongation and drug interactions. 
  • Refer to flowchart and patient scenarios for further detail.

 

August 2023 update:

This bulletin is in the process of being replaced with a Medicines Update blog series on QT prologation. Blogs in the series published to date include:

Read More...

MUE 07: DOAC Prescribing

Posted: Wednesday, March 28, 2018

Category - Medicines Update Extra

DOAC Prescribing in Patients with Non-Valvular AF and for the Treatment and Prevention of VTE

** This bulletin supersedes MUE 05 **

The FAQ includes:

  • Questions relating to indications/appropriateness of DOACs
  • Questions relating to choice of DOAC & dose
  • Questions relating to DOAC initiation
  • Further information and advice
  • Decision making algorithms

April 2023 update:

This bulletin is in the process of being replaced with a Medicines Update blog series on DOACs. Blogs in the series published to date include:

Read More...